Clear Search sequence regions

Results of long-term treatment with Cosaldon A + E in 173 patients (= 345 eyes) exhibiting various stages of degenerative maculopathy are presented (5 tables and 4 figures). Depending on the initial status up to 80% of the treated eyes responded positively to this therapy with only a small side-effect rate: these results suggest that Cosaldon A + E is a promising alternative in the treatment of degenerative maculopathy.


P Flamm. Therapy of degenerative maculopathy with Cosaldon A + E]. Klinische Monatsblätter für Augenheilkunde. 1987 Jan;190(1):59-66

Expand section icon Mesh Tags

Expand section icon Substances

PMID: 3106705

View Full Text